A review and assessment of proposed rule changes governing 340B programs.
Anthony Zappa, PharmD, MBA
Advertisement
Articles by Anthony Zappa, PharmD, MBA
With continued increases in the US drug spend, the evolution of fully transparent PBM programs has introduced an alternative approach to traditional PBM structures aimed at enhanced utilization and cost control.
Advertisement
Latest Updated Articles
- Is PBM Transparency an Answer to Controlling Rising Drug Costs?
Published: August 21st 2015 | Updated:
- Proposed Rule Changes for 340B Programs: Overview and Impact
Published: October 16th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Breaking News: CVS Buys Rite Aid, Bartell Drugs
2
Young Women With Symptomatic Long COVID At Higher Risk of POTS
3
FDA Approves 1-Minute HIV Self-Test
4
Statins and Metformin Improved Survival in Patients With Triple-Negative Breast Cancer
5
